Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Paul's analysis is always worth thinking about!
"May is just a couple of weeks away. I wonder what has the shorts so spooked of late besides those 56M shares shorted with not enough time or sellers to cover. Let’s see now there’s... the earnings report. Probably not though I would love to know how much the Institutional investors have lifted their shares.
*The May 6-8 Vatican conference. Lots of possible worldwide visibility with a top notch PR team would do wonders for Sorrento, and the companies SP.
*The PSS arbitration hearing. Should there be a settlement this year, and not pushed back into next year SP will definitely move upwards.
*Maybe Celularitys scheduled merger this quarter will be in May? It would definitely help turn the screws, but perception wise not enough. Though reality is it’s more easy cash revenue to move trials along should Sorrento choose to do so.
*Announcement of data, and EUA application/approval for Abivertinib (covid). That would sky rocket SP, and definitely a very real possibility for April/May.
*MSC data and EUA very real possibility as well. The MSC P2 Trials are scheduled for multiple sites in US, Brazil, and Mexico, and most likely already ongoing in both Brazil and US.. Most EUA’s are given in P2 trials.
*STIX & ANP are intertwined. STIX EUA means BO ANP, and SP goes straight up.
* AMG trials. The P2 trials are so hush hush you can’t get a peep out of Ji. What would happens if DARPA says we’re taken over, while still in P2, because of outstanding results. SP skyrockets.
* There’s other news that would skyrocket the SP, but probably not until later this year. One last possibility, which could happen anytime this year or next is a minority stake by a big pharma in Sorrento. Even as a minority stake it would be very expensive. It’s fun to dream because several of these events will happen in May, and the rest later this year. The one exception is a big pharma taking a stake in Sorrento. That’s a wild card. Know what you own."